Clearance mechanism of a mannosylated antibody–enzyme fusion protein used in experimental cancer therapy

By Kogelberg Heide   Tolner Berend   Sharma Surinder K.   Lowdell Mark W   Qureshi Uzma   Robson Mathew   Hillyer Tim   Pedley R. Barbara   Vervecken Wouter   Contreras Roland   Begent Richard H.J.   Chester Kerry A.  

Glycobiology, Vol. 17, Iss. 1, 2007-01 ,pp. : 36-45

Oxford University Press

Access to resources Recommend Favorite

Expression and Ligand Binding Assays of Soluble Cytokine Receptor–Immunoglobulin Fusion Proteins

By Brown S.J.   Becherer K.A.   Blumeyer K.   Kautzer C.   Axelrod F.   Le H.   McConnell S.J.   Whalley A.   Spinella D.G.  

Protein Expression and Purification, Vol. 14, Iss. 1, 1998-10 ,pp. : 120-124

Academic Press

Access to resources Recommend Favorite

Anthrax Fusion Protein Therapy of Cancer

By  

Current Protein and Peptide Science, Vol. 3, Iss. 4, 2002-08 ,pp. : 399-407

Bentham Science Publishers

Access to resources Recommend Favorite

Radiolabeled Peptides and Proteins in Cancer Therapy

By  

Protein and Peptide Letters, Vol. 14, Iss. 3, 2007-03 ,pp. : 273-279

Bentham Science Publishers

Access to resources Recommend Favorite

Antibody-directed enzyme prodrug therapy (ADEPT) for cancer

By Bagshawe Kenneth D   Sharma Surinder K   Begent Richard HJ  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 11, 2004-11 ,pp. : 1777-1789

Informa Healthcare

Access to resources Recommend Favorite